NovaBay Pharma (NBY) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.37), $0.04 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.27 million versus the consensus estimate of $3.54 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
